Drug
Iron sucrose clinical trials
Also written Venofer.
How each study uses iron sucrose is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the iron sucrose studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 6 Nov 2000 · VENOFER · NDA 021135 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Development codes
- Fermed® 100mg
- 1
Studies by the year they started
63 studies that test it; most in 2008 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2010 | 3 |
| 2011 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 6 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 50
American Regent, Inc. (8) · Sichuan Huiyu Pharmaceutical Co., Ltd (2) · Denver Health and Hospital Authority (2) · Hospital Clinic of Barcelona (2) · Watson Pharmaceuticals (2) · University of Oxford (2) · Beni-Suef University (1) · Arrowhead Regional Medical Center (1)
Often tested with
Tested in the same studies.
Ferric carboxymaltose (4) · Erythropoietin (3) · Epoetin beta (3) · Iron isomaltoside 1000 (3) · Lactoferrin (2) · Ferric gluconate (2) · Iron (1) · Deferasirox (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 2 phase 3 studies under way
Iron sucrose is the comparator. A study of two new drugs counts under both.
- 2Ferrosoferric Oxide · AMAG Pharmaceuticals, Inc.
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test iron sucrose, phase 3 first.
- Dec 2026Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyPhase 3 · Saskatchewan Health Authority - Regina Area
- Dec 2026Management of Iron Deficiency Anemia in Hemodialysis PatientsPhase 2 · Beni-Suef University
- Feb 2027Iron Replacement to Reduce Anemia During Neoadjuvant ChemotherapyPhase 2 · Fox Chase Cancer Center
- Jun 2027COMPARISON OF EFFICACY OF ORAL VS IV IRON THERAPY IN CHILDREN AGED 12-59 MONTHS, WITH IRON DEFICIENCY ANEMIAPhase 2 · Kharadar General Hospital
- Sep 2027Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaPhase 4 · Western Galilee Hospital-Nahariya
Studies
Open first, then newest update. How each study uses iron sucrose is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 66
- Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaRecruitingPhase 4Western Galilee Hospital-NahariyaNCT06061393Written as Venofer 200 MG Per 10 ML Injection
- Comparing Two Intravenous Iron Treatments for Anemia in Kurdish Pregnant WomenNot yet recruitingNot applicableHawler Medical UniversityNCT07721519Written as Iron Sucrose (IS) Infusion
- COMPARISON OF EFFICACY OF ORAL VS IV IRON THERAPY IN CHILDREN AGED 12-59 MONTHS, WITH IRON DEFICIENCY ANEMIANot yet recruitingPhase 2Kharadar General HospitalNCT07657091Written as iron sucrose
- Iron Replacement to Reduce Anemia During Neoadjuvant ChemotherapyRecruitingPhase 2Fox Chase Cancer CenterNCT05800600Written as Venofer
- Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyRecruitingPhase 3Saskatchewan Health Authority - Regina AreaNCT05251493Written as Iron sucrose
- Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of AnemiaNot yet recruitingPhase 4Ain Shams UniversityNCT05921968Written as Intravenous iron sucrose
- Iron Supplementation for Geriatric Hip FracturesRecruitingPhase 4He QifeiNCT05489952Written as iron sucrose and ferrous lactate
- Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency AnemiaCompletedPhase 3Arrowhead Regional Medical CenterNCT06366698Written as Venofer 200 MG Per 10 ML Injection
- Management of Iron Deficiency Anemia in Hemodialysis PatientsActive, not recruitingPhase 2Beni-Suef UniversityNCT07706582Written as IV iron sucrose
- Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease PatientsCompletedNot applicableSindh Institute of Urology and TransplantationNCT06994065Written as Iron Sucrose injection
- Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal PatientsCompletedNot applicableMuhammad Aamir LatifNCT07115121Written as Intravenous Iron Sucrose
- Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving EpoetinCompletedPhase 2American Regent, Inc.NCT00239616Written as Iron Sucrose injection
- Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on DialysisCompletedPhase 3American Regent, Inc.NCT00236964Written as Iron Sucrose + Erythropoietin
- Bioequivalence Study of Iron Sucrose Injection in Healthy ParticipantsCompletedPhase 1Sichuan Huiyu Pharmaceutical Co., LtdNCT06674486Written as Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer)
- Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron DeficiencyCompletedPhase 4Cheng-Hsin General HospitalNCT06703411Written as Iron Sucrose IV
- Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) PatientsCompletedPhase 4American Regent, Inc.NCT06690450Written as Venofer® 200 mg
- Bioequivalence Study of Iron Sucrose Injection in Healthy SubjectsCompletedPhase 1Sichuan Huiyu Pharmaceutical Co., LtdNCT06622148Written as Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer)
- Iron Therpay and Fatigue in Women of Reprodcutive AgeCompletedNot applicableCentral Park Medical CollegeNCT06596161Written as Iron sucrose
- Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease PatientsCompletedPhase 4Centre Hospitalier Hassan II - FèsNCT06556134Written as Intravenous Iron Sucrose
- Colorado-Oregon Altitude StudyCompletedPhase 4University of OregonNCT05734716Written as Iron sucrose (Venofer)
See all 66 studies that test iron sucrose →
Given beside what is tested · 3 — iron sucrose is usual care or a partner of the new treatment
- Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted AnemiaTerminatedPhase 2Unity Health TorontoNCT03528564Written as Iron sucrose
- A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum AnemiaCompletedNot applicableHaEmek Medical Center, IsraelNCT02458625Written as Iron sucrose 500 mg
- Intravenous Treatment of Anemia in PregnancyCompletedPhase 4University of ZurichNCT03317210Written as iron sucrose (200 mg VENOFER®)
As the comparator · 19 — what is tested is compared with iron sucrose
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)RecruitingPhase 3AMAG Pharmaceuticals, Inc.NCT03619850Written as Iron sucrose
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingPhase 3AMAG Pharmaceuticals, Inc.NCT03893045Written as Iron sucrose
- Iron Administration Via Colonic TET Combined With WMT for IDNot yet recruitingPhase 2The Second Hospital of Nanjing Medical UniversityNCT06487299Written as Iron sucrose
- Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant WomenCompletedPhase 4CMH Multan Institute of Medical SciencesNCT06911034Written as Iron Sucrose Injection
- A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedPhase 2AMAG Pharmaceuticals, Inc.NCT01052779Written as Iron Sucrose
- A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency AnemiaCompletedPhase 3AMAG Pharmaceuticals, Inc.NCT01114204Written as Iron Sucrose
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedPhase 4AMAG Pharmaceuticals, Inc.NCT01227616Written as Iron Sucrose
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency AnaemiaCompletedPhase 3Vifor (International) Inc.NCT03591406Written as Iron sucrose
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney DiseaseCompletedPhase 3Pharmacosmos A/SNCT02940860Written as Iron sucrose
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)CompletedPhase 3Pharmacosmos A/SNCT02940886Written as Iron sucrose
- IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron SucroseCompletedPhase 3Pharmacosmos A/SNCT02130063Written as iron sucrose (Venofer®)
- Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male VolunteersCompletedPhase 1Azad Pharma AGNCT03093883Written as Venofer
- Efficacy Study of Intravenous Iron Preparation to Iron Deficiency AnemiaCompletedPhase 3Zeria PharmaceuticalNCT02731534Written as Saccharated Ferric Oxide
- Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal FunctionCompletedPhase 3American Regent, Inc.NCT00981045Written as Iron Sucrose (Venofer)
- Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in WomenCompletedPhase 2American Regent, Inc.NCT01290315Written as Iron Sucrose / Iron Dextran
- Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically IllWithdrawnPhase 1Denver Health and Hospital AuthorityNCT02009943Written as Iron sucrose
- Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal FailureCompletedPhase 2/3Ottawa Hospital Research InstituteNCT00318812Written as Iron sucrose (Venofer)
- Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult VolunteersCompletedPhase 1Azad Pharma AGNCT02391181Written as Venofer®
- FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORCompletedPhase 3Vifor PharmaNCT00810030Written as Iron Sucrose
Codes
What other systems call iron sucrose · ClinicalTrials.gg INT006775
- MeSH (NLM) D000077605Ferric Oxide, SaccharatedConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) FZ7NYF5N8LIRON SUCROSEConfirmed FDA, NLM, Wikidata
- RxNorm 24909Confirmed FDA, Wikidata
- Wikidata Q27888379iron sucroseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65963Iron SucroseOne source FDA
- DrugBank DB09146One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077605 | Ferric Oxide, Saccharated | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | FZ7NYF5N8L | IRON SUCROSE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 24909 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27888379 | iron sucrose | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65963 | Iron Sucrose | One source FDA |
| DrugBank | DB09146 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.